Search Results
Mar 27, 2026, 13:17 ET Critical Path Institute spúšťa program „One to Millions" - zmena budúcnosti individualizovanej medicíny v globálnom meradle
to Millions rozvíja regulačný rámec amerického Úradu pre kontrolu potravín a liečiv (FDA) pre zriedkavé ochorenia (Plausible Mechanism Framework and Rare Disease Evidence Principles) s využitím centralizovanej dátovej platformy C-Path s regulačným štandardom na podporu generovania dôkazov, regulačného
More news about: Critical Path Institute
Mar 27, 2026, 12:21 ET Blood Health Campaign Launches Nationwide on March 27
This year's initiative highlights critical topics including blood cancer, rare blood disorders, patient access to care, treatment innovation, and the importance of early detection and education. Through compelling storytelling
More news about: Mediaplanet
Mar 27, 2026, 10:22 ET Lisa G. Roth, MD, Named Director of Pediatric Hematology-Oncology at Hassenfeld Children's Hospital at NYU Langone
affect the immune system—in children, adolescents, and young adults. Her work focuses on several types of lymphoma, including Hodgkin lymphoma and other rare forms that can affect younger patients. Through research funded by the National Institutes of Health, she studies how these cancers develop and behave
More news about: Hassenfeld Children's Hospital at NYU Langone
Mar 27, 2026, 10:01 ET Global Paediatric Consumer Health Market to Reach USD 254 Billion by 2032 Amid Growing Focus on Child Wellness and Nutrition, Reports Vyansa Intelligence
OintmentsBy Age Group: Infants & Toddlers, Children, AdolescentsBy Treatment Type: Acute, Chronic, Genetic & Rare DiseasesBy Sales Channel: Retail Online (Online Pharmacies, E-commerce Platforms, Brand Websites), Retail Offline (Hospital Pharmacies,
More news about: Vyansa Intelligence
Mar 27, 2026, 09:47 ET A Parade, a Tuxedo, and a New Heart: Wyatt Goes Home After 351 Days
Year of WaitingWyatt was admitted to Hassenfeld Children's Hospital on October 14, 2024. He was born with hypoplastic left heart syndrome, a rare congenital heart defect in which the left side of the heart is severely undeveloped. Children born with this condition often undergo a series of complex
More news about: Hassenfeld Children's Hospital at NYU Langone
Mar 27, 2026, 09:00 ET DEEPX Secures 27 Commercial Orders Across 8 Countries Within 7 Months of Mass Production
global distribution network early in its commercialization phase through partnerships with Avnet, DigiKey, and WPG. Industry analysts note that it is rare for an emerging fabless semiconductor company to secure a global supply chain at such an early stage of mass production.In Europe, DEEPX signed
More news about: DEEPX
Mar 27, 2026, 08:08 ET Sterile Processing Moves to the Executive Agenda as Surgical Directions Launches Expert Panel Series for Hospital Leaders
exponentially greater impact when delays disrupt surgical schedules and staffing. Per Surgical Directions' CEO, Leslie Basham's experience, although rare, " SPD can shut down an OR when serious issues occur. In a 15 OR hospital if you were to lose 5 cases a day at $10,000 contribution margin (CM) per
More news about: Surgical Directions
Mar 27, 2026, 07:30 ET Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge
Keenova Therapeutics is a leading U.S.-focused branded therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives.Keenova's rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of specialty
More news about: Keenova Therapeutics
Mar 27, 2026, 03:56 ET Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
DirectorsSobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2025, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Mar 27, 2026, 03:52 ET Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
DirectorsSobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2025, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Mar 26, 2026, 23:30 ET Marketing and Communications Executive Who Has Transformed Brands Across Healthcare, Industrials, and Professional Services, Sarah McHugh, Joins Telesto to Lead Growth Services
strategiesBrand and narrative development for complex organizationsIntegrated go-to-market and demand generation programs"Sarah brings a rare combination of strategic clarity and executional discipline," said Alex Kruzel, d CEO of Telesto. "As our clients increasingly demand not just insight,
More news about: Telesto
Mar 26, 2026, 19:52 ET FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and
More news about: Novo Nordisk
Mar 26, 2026, 17:50 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
oral tablet intended to treat hyperphagia. Soleno has described this condition as "the most life-limiting aspect" of Prader-Willi Syndrome ("PWS"), a rare genetic disorder that causes physical, mental, and behavioral problems.The report triggered a massive 26% selloff in the price of the company
More news about: Hagens Berman Sobol Shapiro LLP
Mar 26, 2026, 16:37 ET QURE SHAREHOLDER ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
history as a comparator.Ineligibility for "Plausible Mechanism" Pathway: The official disputed AMT-130's eligibility for streamlined rare-disease pathways, noting it is not an individualized treatment.The recent reports follow the filing of a securities class action suit.Investors
More news about: Hagens Berman Sobol Shapiro LLP
Mar 26, 2026, 16:15 ET L Catterton Real Estate and Cedar Capital Partners Launch Strategic Luxury Hospitality Platform with Two Iconic Luxury Hotel Acquisitions in France and Portugal
Garden Beach Hotel, a 177-key beachfront property located in Juan-les-Pins (Antibes, French Riviera). Currently closed, the hotel represents a rare seafront repositioning opportunity and is expected to be redeveloped into one of the Riviera's flagship luxury destinations.Penha Longa Resort,
More news about: L Catterton
Mar 26, 2026, 15:25 ET Horizon Media Holdings Names Bhavana Smith Chief Operating Officer, Advancing AI-Led Transformation
approach. We are replacing them, rebuilding our operating model from first principles, and aligning incentives to business performance. Bhavana brings a rare ability to build bridges across the agency and industry, and alongside this leadership cohort, ensures we move with speed and conviction."Smith
More news about: Horizon Media
Mar 26, 2026, 14:17 ET Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
we have built a robust and scalable process to bring individualized ASO medicines to nano-rare patients. We have discovered and developed more than 25 ASOs that have enabled treatment of more than 45 nano-rare patients to date. Many of these new ASO medicines can be used to treat more patients and we
More news about: Critical Path Institute
Mar 26, 2026, 14:02 ET Taste of Iceland Festival Returns to D.C. April 23-25
sound, storytelling, and guided meditation inspired by the elemental forces behind one of the world's most extraordinary natural wonders. Born from a rare convergence of geothermal heat and seawater, the Blue Lagoon's bioactive waters are rich in minerals and history. Led by a Blue Lagoon wellness expert,
More news about: Taste of Iceland
Mar 26, 2026, 14:01 ET Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
we have built a robust and scalable process to bring individualized ASO medicines to nano-rare patients. We have discovered and developed more than 25 ASOs that have enabled treatment of more than 45 nano-rare patients to date. Many of these new ASO medicines can be used to treat more patients and we
More news about: Critical Path Institute
Mar 26, 2026, 13:30 ET Unlikely Collaborators Hosts Journalist and Author Eliot Stein
2026 /PRNewswire/ -- Across the world, small communities continue to preserve remarkable forms of knowledge passed down through generations: from rare crafts and intricate rituals to traditions that require years of apprenticeship to master. These practices are not simply relics of the past. They are
More news about: Unlikely Collaborators
Mar 26, 2026, 13:30 ET SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors with Losses to Contact the Firm
INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:Soleno is a pharmaceutical company focused on developing therapies for rare diseases and is headquartered in Redwood City, California. At the time of the filing of the complaint, Soleno's only commercial product was diazoxide
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 26, 2026, 13:23 ET Kiawah Island Luxury Market Enters Spring with Momentum, Limited Inventory, and Rising Buyer Urgency
relocation buyers from the Northeast, Mid-Atlantic, and West Coast — drawn by Charleston's unmatched quality of life, favorable tax climate, and the rare combination of natural beauty and world-class amenities that define life on Kiawah and Seabrook Islands.At the same time, the supply of truly
More news about: Pam Harrington Exclusives, Inc.
Mar 26, 2026, 13:10 ET Norgine annuncia l'approvazione da parte di Swissmedic di PEDMARQSI® per la prevenzione della perdita dell'udito indotta da cisplatino nei bambini
dollari. In Norgine, l'innovazione guida la nostra missione: fornire farmaci che cambiano la vita. Dalle patologie comuni come la stitichezza alle malattie rare e gravi come il cancro infantile, ci concentriamo sulle esigenze mediche non soddisfatte perché crediamo che ogni scoperta scientifica meriti di raggiungere
More news about: Norgine
Mar 26, 2026, 12:43 ET Nearly 500 Leaders Unite to Call America Back to Scripture Post-Easter
gathering but as a growing movement focused on discipleship, Scripture engagement and long-term spiritual renewal."America Reads the Bible is a rare moment of unity, bringing leaders and everyday Americans together around the power of God's Word," said
More news about: Great American Pure Flix
Mar 26, 2026, 12:23 ET Debate Program at Fairmont Preparatory Academy Equips Students to Elevate Public Discourse Through Evidence, Nuance, and Respect
discipline that is becoming increasingly rare nationwide due to staffing and budget constraints."Many debate programs across the country are student-led clubs after school," said Carolyn Lucia, Head of School at Fairmont Prep. "It's exceptionally rare to have a full-time director, coaching support,
More news about: Fairmont Schools